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Abstract: Molecular oxygen has been known to play a critical role in a wide range of biological processes including 
glycolysis, mitochondrial respiration, angiogenesis, pulmonary functions, and cardiovascular activities. An emerging theme 
has developed in recent years that oxygen has signiﬁ  cant impact on embryonic development, maintenance of stem cells, 
and cellular differentiation or cell fate decisions. Among the notable observations, early embryonic development takes place 
in a hypoxic microenvironment. Hematopoietic stem cells appear to be located in hypoxic regions within the bone marrow. 
Majority of the current observations have shown that hypoxia seems to prevent cellular differentiation and to maintain 
pluripotency of stem/progenitor cells. Genetic studies have demonstrated a critical role of hypoxia-inducible factors 1α and 
2α in embryonic development. These intriguing observations demonstrate an important role of molecular oxygen in such 
fundamental biological processes as stem cell maintenance and regulation of cell fate decisions. Herein, we describe some 
of the latest advances in the biology of molecular oxygen and provide our perspectives on the potential impact of these 
interesting ﬁ  ndings.
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Introduction
Molecular oxygen (O2) is an essential element for life on earth. It is the ultimate electron acceptor in 
the mitochondrial electron transport chain and is the only cellular nutrient in a gaseous form. A large 
family of oxidoreductases, such as prolyl hydroxylases and cytochrome c-oxidase use O2 as a substrate 
(Ozer and Bruick, 2007; Vanderkooi et al. 1991). Increasing amounts of evidence also indicate that O2 
functions as a signaling molecule, regulating a wide range of biological processes including erythro-
poiesis, angiogenesis, energy metabolism, and cellular differentiation. Over the past 5–10 years, a new 
role of oxygen has emerged as an important signaling molecule for the regulation of stem cell mainte-
nance and cell fate decisions.
In the current geological era, the atmospheric O2 level reaches approximately 21% at sea level, but 
reduces with increasing elevation. Living organisms, especially mammals, rely on sophisticated respiratory-
circulatory systems to constantly deliver O2 to tissues in order to sustain cellular functions and viability. 
Hypoxia occurs when tissue oxygenation decreases to a certain level, which can result from pulmonary 
obstruction, cardiovascular malfunction, severance of blood vessels, and growth of solid tumors. None-
theless, hypoxia is only an operational term because physiological levels of O2 partial pressures (pO2) 
vary from tissue to tissue (Vaupel et al. 2007). Based on consensus in current literature, hypoxia is con-
sidered as pO2  2% at which the widely used hypoxia marker, the hypoxia-inducible factor-1α (HIF-1α) 
is robustly stabilized and becomes competent for activation transcription of target genes.
The hypoxia-inducible factor-1 (HIF-1) pathway is the best-studied molecular mechanism of O2 
homeostasis in higher eukaryotes. HIF-1 is a heterodimeric transcription factor consisting of HIF-1α 
and HIF-1β, both of which are members of the basic helix-loop-helix Per, AhR and Sim (bHLH-PAS) 
family (Semenza, 2000; Wang et al. 1995). Under physiological normoxia, HIF-1α protein becomes 
hydroxylated at two proline residues located in its O2-dependent degradation domain (Ivan et al. 2001; 
Jaakkola et al. 2001) and is targeted by the von Hippel-Lindau (VHL) protein for ubiquitination and 
proteosome-mediated degradation (Maxwell et al. 1999; Ohh et al. 2000). Under hypoxia, HIF-1α 
protein is not hydroxylated. The stabilized HIF-1α translocates into the nucleus where it dimerizes with 44
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the O2-independent HIF-1β and initiates gene 
transcription by binding to hypoxia-responsive 
enhancer elements (HRE) with the consensus 
sequence of 5’-ACGTG-3’ (Harris, 2002; Semenza, 
2000). Genes induced by HIF-1 are involved in a 
wide range of cellular functions such as cell 
growth, survival, motility, angiogenesis, energy 
metabolism, and cellular differentiation (Harris, 
2002; Lin et al. 2006; Semenza, 2000; Yun et al. 
2005; Yun et al. 2002). As a homologue of HIF-1α, 
the endothelial PAS domain protein (EPAS), now 
known as HIF-2α, also interacts with HIF-1β. 
HIF-2α shares the same mechanism of O2 regula-
tion with HIF-1α but seems to have limited tissue 
distribution (Ema et al. 1997; Tian et al. 1998; 
Wiesener et al. 2003). Further discussion of the 
HIF pathway can be found in many excellent 
reviews that have dealt with this subject in great 
detail. This review will provide a brief account on 
our current understanding of the role of O2 in the 
regulation of cellular differentiation.
Hypoxia and Embryonic 
Development
The embryonic development at early stages likely 
occurs in a physiologically hypoxic microenviron-
ment. During the ﬁ  rst trimester, the average pO2 
level in human placentas is approximately 18 
mmHg (2.4%) as measured by a polarographic O2 
microelectrode, which is signiﬁ  cantly lower than 
average pO2 of 40 mmHg or 5.3% in adjacent 
endometrium (Rodesch et al. 1992). An indepen-
dent study has also shown that the placental pO2 is 
2.5 fold lower than the decidual pO2 before the 
11th week of gestation in humans (Jauniaux et al. 
2001). It is therefore conceivable that pO2 in the 
developing embryo would be lower than 2%. The 
importance of cellular response to hypoxia in 
embryonic development and differentiation has 
been clearly demonstrated in genetic mouse models. 
Homozygous deletion of either HIF-1α or HIF-1β 
is found to be embryonically lethal in mice. The 
HIF-1α
-/- mouse embryos succumb during mid-
gestation around 10 days post coitus (d.p.c) to loss 
of mesenchymal cells and impaired cardiovascular 
development (Carmeliet et al. 1998; Iyer et al. 
1998; Ryan et al. 1998). The HIF-1β
-/- mouse 
embryos die by 10.5 d.p.c due to vascular deﬁ  cien-
cies in the yolk sac and/or placenta (Kozak et al. 
1997; Maltepe et al. 1997). However, mouse phe-
notypes caused by homozygous deletion of HIF-2α 
vary depending on the strains used for generation 
of HIF-2α
-/- mice. Prominent phenotypes include 
embryonic lethality due to cardiovascular defects, 
embryonic and postnatal death due to mitochondrial 
abnormalities, and perinatal lethality resulting from 
impaired pulmonary development (Compernolle 
et al. 2002; Peng et al. 2000; Scortegagna et al. 
2003; Tian et al. 1998). Nonetheless, it has been 
shown genetically that HIF-2α directly enhances 
the transcription of Oct-4 during embryonic devel-
opment by binding to the Oct-4 gene promoter 
(Covello et al. 2006). These genetic models suggest 
that HIF-1α is essential for early embryonic devel-
opment, whereas HIF-2α may be required for late 
fetal development of certain tissue types.
The establishment of uteroplacental circulation 
relies on cytotrophoblast invasion into the uterine 
spiral arterioles. A large body of evidence has 
shown that proliferation, invasion and differentia-
tion of cytotrophoblasts are tightly regulated along 
the pO2 gradient from the anchoring villi in the 
inner placental space with low pO2 to the uterine 
spiral arterioles with high pO2 (Caniggia et al. 
2000; Genbacev et al. 1997; James et al. 2006). In 
the low pO2 microenvironment, cytotrophoblasts 
proliferate as extravillous trophoblasts with a 
poorly differentiated phenotype and invade into 
the surrounding tissue. As they enter into the prox-
imity of O2-rich uterine spiral arterioles, the pro-
liferating extravillous trophoblasts differentiate 
into a highly invasive phenotype and penetrate into 
the arterial endothelium.
However, it remains to be clearly understood 
what role the HIF pathway plays in the regulation 
of growth and differentiation of trophoblasts. 
Caniggia et al. analyzed HIF-1α expression in 
human placenta sections at different gestational 
stages using in situ hybridization and RT-PCR 
(Caniggia et al. 2000). Levels of HIF-1α mRNA 
are high between 5–8 weeks of gestation, but 
decline in the 9th week of gestation. Expression of 
HIF-1α mRNA is robust in the trophoblast layers 
but much weaker in the mesenchyme (Caniggia 
et al. 2000). By Northern blotting analysis, Raja-
kumar and Conrad have found that HIF-1α mRNA 
does not change signiﬁ  cantly with the gestational 
stage, whereas HIF-2α mRNA markedly increases 
with advancing gestation (Rajakumar and Conrad, 
2000). Nonetheless, both HIF-1α and HIF-2α 
proteins decrease with gestational age (Rajakumar 
and Conrad, 2000). The overall dynamic change 
of HIF-1α and HIF-2α proteins coincides with 45
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increased oxygenation at the end of the first 
trimester.
Surprisingly, Maltepe et al. have recently shown 
that both HIF-1α and HIF-2α mRNA increase 
dramatically during in vitro differentiation of tro-
phoblast stem cells, and the increased transcription 
of HIF-1α and HIF-2α mRNA occurs at 21% O2 
(Maltepe et al. 2005). Increasing amounts of HIF-
1α and especially HIF-2α proteins are also found 
in differentiated trophoblast cells (Maltepe et al. 
2005). The observations by Maltepe et al. certainly 
do not agree with those by Caniggia et al. and by 
Rajakumar and Conrad as discussed above. The 
discrepancies are likely to be caused by different 
experimental approaches. While others used 
ex vivo human placental tissues, Maltepe et al. used 
an in vitro model of trophoblast stem cells initially 
derived from mouse embryonic ﬁ  broblasts. There-
fore, the contradictory observations could poten-
tially be attributed to differences between human 
and mouse tissues and/or among different cellular 
origins.
Nevertheless, the consensus of these studies is 
that HIF-2α seems to be regulated by a different 
mechanism in trophoblasts in contrast to HIF-1α. 
Expression of HIF-2α mRNA (Maltepe et al. 2005; 
Rajakumar and Conrad, 2000) and HIF-2α protein 
(Maltepe et al. 2005; Rajakumar and Conrad, 2000) 
increases in trophoblasts with gestational age, 
while HIF-1α mRNA remains largely unchanged. 
Consistent with these observations, expression of 
HIF-2α mRNA increases with adipogenic differ-
entiation and HIF-2α protein is regulated by 
O2-independent mechanisms in adipocytes (Lin 
et al. 2006). Such differential regulation of HIF-1α 
and HIF-2α may reﬂ  ect their pleiotropic functions 
during cellular differentiation. Genetic models will 
be required to delineate the functions of HIF-1α 
and HIF-2α during placental development and 
trophoblast differentiation.
The role of HIF-1 in lymphocyte development 
has been studied using an RAG-2
-/- blastocyst 
complementation assay (Kojima et al. 2002; 
Kojima et al. 2003). In chimeric mice generated 
by injecting HIF-1α
-/- embryonic stem cells into 
RAG-2
-/- blastocysts, the BM-derived HIF-1α
-/- B-
cells were developmentally blocked in the late 
pre-B stage (Kojima et al. 2002). In contrast, T-cell 
development in the thymus of HIF-1α
-/-/RAG-2
-/- 
chimeric mice is not affected, nor is the extra-
medullar B cell development (Kojima et al. 2002; 
Kojima et al. 2003). These observations suggest 
that HIF-1α plays a differential role in development 
of B and T cells.
Hypoxia and Differentiation of 
Bone Marrow-Derived Stem Cells
Early studies of hematopoietic regeneration after 
bone marrow (BM) ablation by ionizing radiation 
revealed the existence of a radioresistant popula-
tion of hematopoietic stem cells (HSC) (Maloney 
and Patt, 1968; Rubin et al. 1977). The radioresis-
tance of these HSCs may reﬂ  ect their existence in 
a relatively hypoxic microenvironment with lower 
pO2 than other well-vascularized and well-
oxygenated areas (Allalunis et al. 1983). In healthy 
human volunteers, the mean hemoglobin O2 satu-
ration in BM aspirates was found to be about 
87.5%, much lower than the 99% hemoglobin O2 
saturation in peripheral blood (Harrison et al. 
2002). Using an oxygen microelectrode to directly 
measure tissue pO2 in situ, Ceradini et al. have 
found that the mean pO2 in mouse BM is around 
18 mmHg or 2.4% O2, as compared to about 
34 mmHg (4.5% O2) in adjacent non-ischemic 
muscle (Ceradini et al. 2004). A recent study has 
shown that the highest concentration of HSCs is 
contained in the cell population with the lowest 
perfusion, as shown by the lowest ﬂ  uorescence of 
the vessel-permeating dye Hoechst 33342 (Parmar 
et al. 2007), suggesting that HSCs are likely local-
ized in regions distant from blood vessels. The 
hypoxic nature of HSCs is further demonstrated 
by their selective binding of the hypoxia-activated 
compound pimonidazole and their increased sen-
sitivity to the hypoxia-activated cytotoxin tirapaza-
mine (Parmar et al. 2007). These data strongly 
support the concept that HSCs are localized in 
hypoxic regions of bone marrow. Nonetheless, the 
exact location of such hypoxic HSC niches needs 
to be clearly determined by immunohistological 
analysis at cellular levels in vivo.
The multipotency of HSCs seems to be main-
tained by hypoxia. Using non-adherent murine 
BM-derived cells, Cipolleschi et al. found that the 
marrow-repopulating potential of HSCs cultured 
at 1% O2 even without stromal cells was higher 
than that of HSCs cultured under ambient tissue 
culture conditions (Cipolleschi et al. 1993), sug-
gesting that the hypoxic culture contains more 
pluripotent stem cells than the normoxic culture. 
Because HSCs lose their pluripotency quickly 
when maintained under normal tissue conditions, 46
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it is also possible that hypoxia maintains 
pluripotency of HSCs. Consistent with these 
findings, Ivanovic et al. showed that hypoxia 
maintained both the colony-forming and marrow-
repopulating potential of murine BM cells better 
than normoxia did (Ivanovic et al. 2000; Ivanovic 
et al. 2002). Danet et al. investigated the effect of 
hypoxia (1.5% O2) on the ability of human 
lin
−CD34
+CD38
− HSCs to reconstitute the BM of 
lethally irradiated severe-combined immunodeﬁ  -
cient (SCID) mice (Danet et al. 2003). Using a 
serial dilution assay, they showed that SCID-
repopulating cells were increased 5.8 fold in 
hypoxic cultures, as compared to cells grown at 
normoxia (Danet et al. 2003). A recent proteomics 
study has further shown that LSK (lin
- Sca-1
+ 
c-Kit
+) HSCs preferentially displayed a proteomic 
profile reminiscent of hypoxia-regulated gene 
expression (Unwin et al. 2006). These observations 
strongly suggest an important role for hypoxia in 
the maintenance of HSC pluripotency.
HSCs are located in a special microenviron-
ment, called the stem cell niche, where their stem 
cell phenotype and differentiation are tightly 
regulated via interactions with the supporting 
stromal cells (Nagasawa, 2006; Wilson and 
Trumpp, 2006; Yin and Li, 2006). As discussed 
above, these HSC niches are likely to be hypoxic. 
Therefore, niche stromal cells are also under the 
inﬂ  uence of hypoxia. Marrow stromal cells can 
be grown in vitro as pluripotent mesenchymal stem 
cells capable of differentiating into osteoblasts, 
adipocytes and chondrocytes. D’Ippolito et al. 
have shown that hypoxia (1%–3% O2) inhibits the 
differentiation and enhances pluripotency of a 
human BM stromal cell line (D’Ippolito et al. 
2006). When exposed to hypoxia, human BM-
derived stromal cells increase expression of a 
subset of genes normally found in embryonic cells 
such as OCT-4 and Rex-1 by RT-PCR (D’Ippolito 
et al. 2006; Grayson et al. 2006), as well as cell-
surface marker SSEA-4 by ﬂ  uorescence-assisted 
cell sorting or FACS (D’Ippolito et al. 2006). Even 
short-term exposure to hypoxia seems to enhance 
pluripotency of BM-derived stem cells. Martin-
Rendon et al. and Grayson et al. have shown that 
hypoxia-preconditioned human BM-derived stem 
cells exhibit higher colony forming units and 
increased differentiation potential towards chon-
drogenic, adipogenic or osteogenic differentiation 
(Grayson et al. 2007; Grayson et al. 2006; Martin-
Rendon et al. 2007).
Current evidence suggests that HIF-1 may be 
directly involved in the regulation of BM-derived 
stem and progenitor cells. Both HSCs and BM 
stromal cells express HIF-1α (D'Ippolito et al. 
2004; Danet et al. 2003; Okuyama et al. 2006). In 
BM stromal cells, HIF-1 is directly involved in the 
enhanced expression of VEGFR1 by hypoxia 
(Okuyama et al. 2006). The expression of stromal-
derived factor-1 (SDF-1) is upregulated by HIF-1 
and plays an important role in hypoxia-induced 
trafficking of BM-derived progenitor cells 
(Ceradini et al. 2004). However, mechanisms of 
hypoxia-signaling in BM-derived stem cells are 
likely to complex involving both HIF-dependent 
and -independent pathways that remain to be fully 
understood.
Maintaining BM stromal cells in a stem cell-like 
state may have signiﬁ  cant ramiﬁ  cations for main-
tenance of HSCs. Studies using transgenic mice 
have shown that ablation of osteoblasts at an early 
stage of osteoblastogenesis results in a severe 
decrease in BM HSCs (Visnjic et al. 2004), whereas 
loss of osteoblasts at later stages of differentiation 
has no effect on hematopoiesis (Corral et al. 1998). 
These data suggest that immature stromal cells are 
better suited for the maintenance of HSCs (Wilson 
and Trumpp, 2006). It is thus conceivable that 
hypoxia contributes to the establishment of an 
undifferentiated niche microenvironment that pre-
vents inopportune differentiation of HSCs.
Hypoxia and Differentiation 
of Mesenchymal Stem/Progenitor 
Cells
Adipogenic differentiation
Several in vitro studies have shown that adipogenic 
progenitor cells are prevented from undergoing 
differentiation by hypoxia (Kim et al. 2005; Lin 
et al. 2006; Sahai et al. 1994; Yun et al. 2002). It 
is worth mentioning that inhibition of adipogenic 
differentiation occurs even at 1%–2% O2, a phys-
iologically relevant level of hypoxia (Lin et al. 
2006; Yun et al. 2002). Interestingly, these pro-
genitor cells remain undifferentiated and uncom-
mitted under hypoxic conditions and can still 
undergo adipogenic differentiation once they return 
to normoxic conditions (Lin et al. 2006). These 
data suggest that hypoxia has the ability to maintain 
stem cell functionality by arresting stem/progeni-
tor cells in an undifferentiated state. This ﬁ  nding 47
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provides a reasonable explanation as to why a 
hypoxic niche may potentially be critical for the 
maintenance of stem cells in vivo.
Mechanistically, hypoxia represses the 
expression of PPARγ2 and C/EBPα, two critical 
differentiation-determination genes during adipo-
genic differentiation (Lin et al. 2006; Yun et al. 
2002). Therefore, hypoxia prevents progenitor cells 
from committing to terminal adipogenic differen-
tiation. HIF-1α is expressed in both progenitor 
cells and differentiated adipocytes, whereas 
HIF-2α is only detected in mature adipocytes (Lin 
et al. 2006; Shimba et al. 2004). These data suggest 
that HIF-1α is more involved in the regulation of 
adipogenic progenitor cells whereas HIF-2α may 
be more important in mature adipocytes. Indeed, 
HIF-1α plays an essential role in inhibiting adipo-
genic differentiation. When HIF-1α is knocked 
down by gene-speciﬁ  c siRNA, progenitor cells 
become capable of adipogenic differentiation under 
hypoxic conditions. On the other hand, ectopic 
expression of constitutively active HIF-1α mutants 
results in inhibition of adipogenic differentiation 
under normoxic conditions (Lin et al. 2006).
Further downstream of the HIF-signaling path-
way, the hypoxia-induced gene DEC1/Stra13 is 
directly involved in inhibition of PPARγ2 transcrip-
tion. DEC1/Stra13, also referred to as BHLHB2, 
SHARP2 and Clast5, is a putative transcription 
repressor and contains an N-terminal basic helix-
loop-helix (bHLH) domain homologous to those 
of the Hairy and Enhancer-of-Split (HES) family. 
Studies have shown that HIF-1 is required for 
hypoxic induction of DEC1/Stra13 transcription 
(Miyazaki et al. 2002; Wykoff et al. 2000; Yun 
et al. 2002). Ectopic expression of DEC1/Stra13 
results in decreased PPARγ2 transcription and 
inhibition of adipogenic differentiation (Yun et al. 
2002). These data demonstrate that signal transduc-
tion mediated by HIF-1 plays a critical role in the 
regulation of adipogenic differentiation.
Other hypoxia-regulated signaling pathways 
may also contribute to the inhibition of adipogenic 
differentiation. In human BM-derived stromal 
cells, hypoxia can activate the Transforming 
Growth Factor β (TGFβ)-Smad pathway by 
increasing levels of phosphorylated Smad2/3, 
which results in inhibition of adipogenic differen-
tiation (Zhou et al. 2005). It will be interesting to 
see whether the canonical HIF-pathway is involved 
in activation of the TGFβ-Smad pathway. We have 
also found that hypoxia increases the expression 
of the stem/progenitor marker pref-1/DLK1 (Lin 
et al. 2006), a negative regulator of adipogenic 
differentiation (Smas and Sul, 1993; Wang et al. 
2006). Enhanced expression of pref-1/DLK1 in 
adipogenic precursor cells is independent of HIF-
1 (Lin et al. 2006). These observations demonstrate 
that both HIF-dependent and HIF-independent 
pathways are involved in repression of adipogenic 
differentiation.
Myogenic differentiation
Hypoxia also inhibits the differentiation of myo-
genic progenitor cells (Gustafsson et al. 2005; Yun 
et al. 2005). However, inhibition of myoﬁ  ber for-
mation depends on the degree of hypoxia, with 
strongest inhibition at nearly anoxic pO2 level (Yun 
et al. 2005). Hypoxia inhibits expression of the key 
myogenic transcription factor MyoD and, to a 
lesser degree, the transcription coactivator E2A 
(Yun et al. 2005). Interestingly, MyoD expression 
is only transiently blocked at 0.5%–2% O2, but 
gradually recovers even when cells are kept under 
hypoxic conditions. Consequently, myogenic dif-
ferentiation manages to adapt to persistent or 
chronic hypoxia (Yun et al. 2005).
In contrast to its role in adipogenesis, HIF-1α 
does not seem to play a signiﬁ  cant role in the 
regulation of myogenic differentiation. Ectopic 
expression of constitutively active HIF1α does not 
change myogenesis under normoxia or hypoxia 
(Yun et al. 2005). Contrary to the above results, 
Gustafsson et al. have reported that HIF-1α is 
involved in inhibition of myogenesis by interacting 
with the Notch intracellular domain (NICD) and 
subsequently activating downstream genes of 
Notch signaling (Gustafsson et al. 2005). However, 
Yun et al. have found that expression of Notch1, 
Notch2 and Notch3 is not signiﬁ  cantly affected at 
0.5% O2, but is markedly reduced at 0.01% O2 
(Yun et al. 2005). Consistently, the level of endog-
enous NICD protein is not signiﬁ  cantly affected at 
1%–2% O2, but is again dramatically reduced at 
0.01% O2. Furthermore, treatment of C2C12 
myoblasts with N-[N-(3,5-diﬂ  uorophenylacetyl-
L-alanyl)]-S-phenylglycine t-butylester (DAPT), 
a speciﬁ  c γ-secretase inhibitor, to block Notch 
signaling by preventing NICD formation has no 
signiﬁ  cant effect on myogenic differentiation under 
normoxic or hypoxic conditions (Yun et al. 2005). 
The observation by Yun et al. suggests that Notch 
signaling is not likely to be involved in the 48
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inhibition of myogenic differentiation. Although 
both studies use the C2C12 model, the inconsistent 
observations might potentially be attributed to dif-
ferences in maintenance of tissue culture and 
experimental conditions such as differentiation and 
hypoxia. The exact mechanisms by which hypoxia 
regulates myogenic differentiation remain to be 
investigated.
Chondrogenic differentiation
Cartilage tissue is avascular and contains regions 
of hypoxia under normal physiological conditions 
(Brighton and Heppenstall, 1971a, b). During 
embryonic development, precartilaginous conden-
sation of mesenchymal cells occurs in an avascular 
microenvironment with gross hypoxia as revealed 
by strong staining of hypoxia-activated nitroimid-
azole compounds, and by immunochemical stain-
ing of HIF-1α (Provot et al. 2007; Robins et al. 
2005). Condensed mesenchymal stem cells thus 
differentiate into chondrocytes for joint formation. 
Genetic mouse model studies using conditional 
knockout of HIF-1α have clearly demonstrated a 
critical role of HIF-1α in chondrogenic develop-
ment. When HIF-1α is deleted in late stage chon-
drocytes using the Col2a1 promoter-drive Cre 
approach, survival of chondrocytes is severely 
reduced (Schipani et al. 2001). When HIF-1α is 
deleted in early stage of chondrogenesis using the 
Prx1 promoter-drive Cre approach, embryos 
develop abnormal cartilaginous primodia and 
impaired joint formation (Amarilio et al. 2007; 
Provot et al. 2007). Expression of Sox9, a key 
regulator of chondrogenesis, is reduced in HIF1α-
deleted limbs (Amarilio et al. 2007). HIF-1α 
regulates Sox9 transcription by directly binding to 
Sox9 promoter (Amarilio et al. 2007). These stud-
ies have provided strong evidence that the HIF-1 
pathway is critically involved in chondrogenic 
differentiation during embryonic development. 
These observations also suggest that mesenchymal 
stem cells may still be able to commit to chondro-
genic differentiation under hypoxic conditions 
in vivo.
Surprisingly, Malladi et al. have found that both 
chondrogenic and osteogenic differentiation of 
adipose-derived adult mesenchymal stem cells are 
inhibited when these mesenchymal cells are 
induced to undergo differentiation in vitro at 2% 
O2 (Malladi et al. 2006). Nonetheless, targeted 
deletion of HIF-1α in adipose-derived adult 
mesenchymal stem cells results in reduced 
chondrogenic growth in vitro and decreased 
expression of chondrogenic genes such as Sox 9 
and collagen II (Malladi et al. 2007). These dis-
crepancies could potentially be appreciated from 
at least two perspectives. (1) Chondrogenic dif-
ferentiation is differentially regulated by HIF-
dependent and -independent pathways under 
hypoxia. It is also worth noting that HIF-1α can 
be regulated by hypoxia-independent mechanisms 
(Harris, 2002; Semenza, 2003). (2) Cell fate deci-
sions are likely determined as a result of interac-
tions between hypoxia and other extracelluar 
stresses in vivo, especially during embryonic devel-
opment. Additional study will be needed to fully 
understand the interactions between hypoxia-
activated pathways and other stress-induced path-
ways that regulate differentiation and maintenance 
of stem cells.
Concluding Remarks
Aerobic life on earth is thought to have begun some 
2 billion years ago when the primitive atmosphere 
was hypoxic with approximately 2%–3% O2 (Han 
and Runnegar, 1992; Massabuau, 2003). A rapid rise 
in atmospheric O2 is estimated to have occurred 
around 1 billion years ago and to reach the present 
day level of 21% for the ﬁ  rst time around 540 million 
years ago (Massabuau, 2003). The last 500 million 
years have witnessed a dramatic ﬂ  uctuation in atmo-
spheric O2 between 35% and 15% (Berner et al. 
2007; Massabuau, 2003). The rise and fall of atmo-
spheric O2 is closely tied to biological evolution on 
earth from speciation to extinction (Berner et al. 
2007). Over the past 205 million years, atmospheric 
O2 rose from approximately 11% to the current level 
of 21%. The latest rise in atmospheric O2 is thought 
to be a key factor during the evolution of large pla-
cental mammals in the Cenozoic Era (Falkowski 
et al. 2005). Although rising O2 tension has been 
linked to increases in animal body size (Berner et al. 
2007), it is quite remarkable that O2 tensions at the 
cellular level remain in a low range, independent of 
inspired O2 tensions (Massabuau, 2003). The role 
of O2 in evolution is yet to be determined, which 
further underscores the importance of O2 biology. 
Investigation of O2-dependent signal transduction 
will lead to the discovery of new cellular mecha-
nisms that govern cellular growth, differentiation, 
and senescence, which will in turn provide insight 
into cellular mechanisms of evolution.49
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